- Email: [email protected]
The epigenetic landscapes of histone modifications on HSV-1 genome in human THP-1 cells
Journal Pre-proof The epigenetic landscapes of histone modifications on HSV-1 genome in human THP-1 cells Gao Chuan, Lin Chen, Shan-Bo Tang, Qiao-Yun Long, Jia-Li He, Na-An Zhang, Hong-Bing Shu, Zhen-Xia Chen, Min Wu, Lian-Yun Li PII:
S0166-3542(19)30334-1
DOI:
https://doi.org/10.1016/j.antiviral.2020.104730
Reference:
AVR 104730
To appear in:
Antiviral Research
Received Date: 11 June 2019 Revised Date:
23 December 2019
Accepted Date: 28 January 2020
Please cite this article as: Chuan, G., Chen, L., Tang, S.-B., Long, Q.-Y., He, J.-L., Zhang, N.A., Shu, H.-B., Chen, Z.-X., Wu, M., Li, L.-Y., The epigenetic landscapes of histone modifications on HSV-1 genome in human THP-1 cells, Antiviral Research (2020), doi: https://doi.org/10.1016/ j.antiviral.2020.104730. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier B.V.
The epigenetic landscapes of histone modifications on HSV-1 genome in human THP-1 cells Gao Chuan1, *, Lin Chen1, *, Shan-Bo Tang1, *, Qiao-Yun Long1, *, Jia-Li He1, Na-An Zhang2, Hong-Bing Shu3, Zhen-Xia Chen2, Min Wu1, #, Lian-Yun Li1, #
1
Hubei Key Laboratory of Cell Homeostasis, Hubei Key Laboratory of
Developmentally Originated Disease, Hubei Key Laboratory of Enteropathy, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China 2
College of Life Sciences and Technology, Huazhong Agriculture University, Wuhan,
Hubei 430070, China 3
Medical Research Institute, College of Life Sciences, Wuhan University, Wuhan,
Hubei 430072, China *
Equal contribution to the study.
Contact information #
Correspondence should be addressed to Dr. Lian-Yun Li, Email:
[email protected], Tel: 86-27-68756672; or Dr. Min Wu, Email: [email protected], Tel: 86-27-68756620 Running title HSV-1 epigenome in THP-1 cells
1
Abstract Histone positioning and modifications on viral genomes are important factors regulating virus replication. To investigate the dynamics of modified histones on the viral genome and their potential roles in antiviral response, we studied the dynamic changes of histone modifications across the HSV-1 genome in THP-1 cells. Histone modifications were detected on the HSV-1 genome soon after infection, including H3K9me3, H3K27me3, H3K4me3 and H3K27ac. These modifications emerged on the viral genome soon after infection and changed rapidly along with virus life cycle progression. The transcription repression marks, H3K9me3 and H3K27me3, decreased on the viral genome during the infection process; the transcription activation mark H3K27ac increased. Treatment with C646, an inhibitor of H3K27ac transferase p300, significantly repressed virus replication and viral gene expression. Our study reveals the relationship between histone modifications and viral gene expression and provides potential novel strategies for antiviral treatment. Key words HSV-1, epigenome, H3K9me3, H3K27me3, H3K27ac, H3K4me3
2
Introduction Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) are members of the herpesvirus family, and HSV-1 is often used as a model organism to study innate immunity against DNA viruses. During lytic infection, HSV-1 usually causes only mild symptoms. However, HSV-1 hides from the immune system in nerve cells (James and Kimberlin, 2015; Thellman and Triezenberg, 2017; Whitley and Roizman, 2001) and leads to latent infection. After entry into cells, HSV-1 injects its genomic DNA into the nucleus, where viral genes are transcribed and the viral genome is replicated. Viral genes are expressed in an ordered pattern of immediate-early (IE), early (E) and late (L) genes (Harkness et al., 2014; Thellman and Triezenberg, 2017; Whitley and Roizman, 2001). A major question in the field is how the ordered expression of these genes is organized and regulated. Histones bind to the viral genome soon after viral DNA enters the nucleus. It is not clear whether the presence of histones and their modifications benefit the ordered viral gene expression and life cycle, or whether they are involved in innate immunity. It has been well demonstrated that histone modifications are critical epigenetic factors in regulating mammalian gene expression (Henikoff and Shilatifard, 2011). H3K9me3 and H3K27me3 are typical repressive marks; H3K4me3 is usually associated with active transcription (Brookes and Shi, 2014; Rickels and Shilatifard, 2018). H3K27ac is another hallmark for actively transcribed genes, which is catalyzed by histone acetyltransferase p300/CBP. It occupies the promoter of active genes, and recently was shown to mark active enhancers (Medina-Rivera et al., 2018; Rickels and Shilatifard, 2018). However, it has been debated whether histones stably bind to HSV-1 genomes and form viral chromatin. Early studies showed that the interaction between histones and viral DNA is weak, based on enzyme digestion assay, suggesting it is unlikely that stable chromatin forms similar to mammalian chromatin (Bhaumik et al., 2007; Kent et al., 2004; Lacasse and Schang, 2012). Later, multiple studies showed that histones, including typical histone modifications, are repeatedly detected on viral genomes, mostly though Chromatin Immunoprecipitation (ChIP) assays (Conn and Schang, 2013; Kristie, 2015; Lacasse and Schang, 2012; Oh et al., 2015). It was reported that formation of heterochromatin marks on HSV-1 genome is critical for ordered gene expression (Cliffe et al., 2009). Inhibition of LSD1, a histone H3K4 demethylase, results in heterochromatic suppression of the HSV-1 genome and subsequently affects viral infection (Hill et al., 2014; Liang et al., 2009). The 3
immediate early gene ICP0 removes heterochromatin marks H3K9me3 and H3K27me3 from viral gene promoters during lytic infection (Lee et al., 2016). Along with the application of epigenomic approaches in viral studies, the epigenomic landscapes of the HSV-1 genome, as well as that of some other viruses, have been elucidated. A recent study mapped the nucleosome positions on HSV-1 genome via high throughput sequencing (Oh et al., 2015). The landscape of histone modifications, including H3K4me3, H3K27me3 and H3K27ac on KHSV genome was also reported in vitro and in vivo (Hilton et al., 2013; Sun et al., 2017; Toth et al., 2013; Toth et al., 2010). However, since the order of HSV-1 gene expression is tightly controlled (Harkness et al., 2014), the epigenetic marks must change dynamically. Therefore, the dynamic epigenetic landscapes of viral genomes after infection should be determined to demonstrate the epigenetic regulation of viral gene expression. In the current study, we investigated the dynamic epigenetic landscape on HSV-1 genomes and explored the potential for a novel antiviral strategy. We provided epigenomic evidence to show that the histone modifications on HSV-1 genomes emerged soon after infection and were highly dynamic during lytic infection. Chemical inhibition of H3K27ac significantly inhibited HSV-1 gene expression and replication, which points out the important role of histone modifications for virus replication and gene expression and suggests a novel strategy for antiviral treatment. Results Histone modifications bound on viral genome soon after infection The occurrence of modified histones on the viral genome was confirmed by ChIP-PCR. THP-1 is a monocyte leukemia cell line and is often used for innate immune studies of DNA and RNA viruses. THP-1 cells were infected with HSV-1 for 1 h and four modifications were studied, including H3K27ac and H3K4me3 for active transcription, and H3K9me3 and H3K27me3 for repressive transcription. Both H3K9me3 and H3K27me3 were easily detected on the gB gene (Fig. 1A & B). The highly expressed host gene GAPDH was a negative control. The transcriptionally repressed host gene MYT1 was a positive control. The H3K9me3 enrichment on gB was comparable to that on MYT1 (Fig. 1A), while H3K27me3 was relatively lower (Fig. 1B). The active gene marks, H3K4me3 and H3K27ac were detected on gB 1 h after infection (Fig. 1C & D), which were lower than the GAPDH positive control and higher than the negative control (the centromere of chromosome 7) (Fig. 1C & D), 4
suggesting the active marks were present at a low level. The enrichment of H3K27ac and H3K4me3 was also measured in Vero cells, which showed a similar pattern as in THP-1 (Sup. Fig. 1). Then we collected cells at different time points after infection, and analyzed the dynamics of histone modifications on gB. Both repressive marks, H3K9me3 and H3K27me3, were highest at the early stage of infection and gradually decreased with time (Fig. 1E & F); the transcription activation mark, H3K27ac was lowest at 1 h and 2 h, then increased later (Fig. 1G). Interestingly, another activation mark, H3K4me3, did not change and maintained a low level (Fig. 1H). Experimental design and data quality for epigenomic study of HSV-1 genome To study the dynamic epigenetic landscape of histone modifications on HSV-1 genomes during lytic replication, we used HSV-1 (MOI = 0.5) to infect THP-1 cells, and collected samples at 1 h, 2 h, 4 h, 8 h and 24 h after infection. The cells were then subjected to RNA-Seq and ChIP-Seq with antibodies recognizing H3K27ac, H3K4me3, H3K9me3 and H3K27me3. Two biological replicates were performed for each sequencing, and data quality control was done before analysis. We found that only a few reads from early time points (1 h and 2 h) were mapped to the HSV-1 genome, probably due to the low copy number of virus. Therefore, we increased the sequencing depth to ensure enough HSV-1 specific data was analyzed. The informatics analysis was then performed with the average level of each modification. During analysis, we found the sequencing depth of some H3K9me3 samples was not equivalent to others in the same experiment, so to ensure the quality of our analysis, we performed another replicate for H3K9me3 and used the average value of three replicates for further study. The dynamic expression pattern of HSV-1 genes The data were mapped to the HSV-1 genome sequence (GenBank Acc: JN555585.1), and since the amount of host cell genome is constant, we used the ratio of the mapped viral sequences to the host genome sequence to represent the average amount of virus DNA in each cell. Viral gene expression was very low at 1 h and 2 h after infection, increased slowly at 4 h to 8 h, and reached a high level at 24 h (Fig. 2A). Since the level of gene expression varied for different viral genes, and the total expression level of host genes was more stable, we normalized the viral RNA with the total human RNA to calculate the expression level of viral genes in each cell. The 5
change in viral gene expression levels reflected the change in DNA copy number: low at 1 h and 2 h, increasing at 4 h, and reaching high levels at 8 h and 24 h (Fig. 2B). Then we normalized the modifications on the viral genome with the human genome to study their average levels in each cell, which again reflected the trends of viral DNA copy number and RNA level (Fig. 2C). These results suggest that the ChIP-Seq signals we detected were probably real signals on the virus genome. The relative reads count of input reflected the increase of viral DNA amount, while the distance between each modification to input samples may reflect the change of enrichment for each modification on viral genomes (Fig. 2C). For instance, H3K27ac level was close to the input amount at 1 h, then rose higher than input at 8 h and 24 h, which means the average H3K27ac level kept increasing on viral genomes (Fig. 2C). To assess the average gene expression level per virus, the normalized RNA-Seq results were further divided by the corresponding ratio of viral copy number; and the dynamic maps of HSV-1 gene expression patterns were generated for different time points, which were similar to a previous report (Fig. 2D) (Harkness et al., 2014), suggesting that our sequencing data were reliable. The patterns of histone modifications on HSV-1 genome Then we analyzed the ChIP-Seq data of four histone modifications and generated their landscapes on the HSV-1 genome at different time points (Fig. 3A-D). We normalized the histone modification data by the relative viral DNA amount, and the results represent the average level of histone modifications on each viral genome. Obvious signals for all four modifications were detected at 1 h after infection, which means HSV-1 DNA was rapidly packaged with modified histones after entering the nucleus (Fig. 3A-D). As time elapsed, the signals for all four histone modifications on HSV-1 genomes changed rapidly. H3K9me3 emerged immediately at 1 h, increased at 2 h and 4 h, then decreased at 8 h (Fig. 3A). The level of H3K27me3 was at high at 1 h and 2 h, and then decreased slowly from 4 h (Fig. 3B). H3K4me3 emerged at 1 h and remained at the same level until 4 h, and then decreased slightly at 8 h (Fig. 3C). H3K27ac was the most dynamic mark. It emerged at 1 h, remained low at 2 h and 4 h, and then increased dramatically at 8 h (Fig. 3D). The signals at early time points (1 h to 8 h) nearly disappeared at 24 h (Fig. 3A-D). The low signals at 24 h do not mean that virus genomes were not modified by histones, since high levels of histone 6
modifications were detected earlier (Fig. 2C). Interestingly, the average gene expression level was low (Fig. 2D), suggesting correlation existed with histone binding. The dynamic changes of the global signals of histone modifications on HSV-1 and host genomes To study the potential functions of these modifications on viral gene expression, we analyzed the dynamic trends for the enrichment of histone modifications on viral genomes. A line diagram was drawn to show the dynamics of each histone modification on viral genomes, as well as the corresponding viral gene expression (Fig. 4A & B). Similar to the results shown in Fig. 3, H3K27ac increased from 4 h to 8 h, while H3K4me3, H3K9me3 and H3K27me3 slowly decreased on viral genomes. To evaluate the consistency of each histone modification on viral genomes, we analyzed their correlation over time. Although HSV-1 expression induced a significant change of gene expression, the correlations of each histone modification among different time points were high, indicating that the epigenetic landscapes on host genome did not change much after infection (Fig. 4C). A relative high correlation between H3K9me3 and H3K27me3 was also observed, probably due to the transcriptional repressive abilities of these two modifications (Fig. 4C). However, the HSV-1 epigenome was different. The correlations among different time points of all four modifications were low (Fig. 4D). Since the expression of viral genes is tightly controlled, the change of these modifications may play important roles during virus infection. The dynamic change of histone modifications on HSV-1 genes To evaluate the correlation between histone modifications and expression of single genes, we calculated the expression level of one gene by adding up all the reads mapped to it, and then normalized by the number of mapped reads to host genome and the corresponding virus DNA amount. Since the HSV-1 coding sequences overlapped (Fig. 2 & 3 bottom), our strategy could not determine the exact expression level and histone modifications of all viral genes. A heat map was generated to show the expression of each viral gene (Fig. 5A), and we generated heat maps for histone modifications of the corresponding gene (Fig. 5B - F). On the genome of eukaryote 7
species, H3K4me3 usually marks transcription start sites (TSS) and H3K27ac usually marks promoters and enhancers. H3K9me3 and H3K27me3 cover the promoters and coding sequences of repressed genes. Among the four modifications, H3K27ac on individual genes was synchronized, supporting it as one of the critical histone modifications for virus (Fig. 5B & C). Though the correlation between H3K27ac and gene expression level was greater than other modifications (Fig. 5C), the 4 h and 8 h results deviated from the trend line, suggesting that the levels of H3K27ac on viral genes does not correlate well with the transcription levels of individual genes. H3K9me3 and H3K27me3 emerged on many viral genes at 1 h, and then peaked at 2 h (Fig. 5D & E). On most genes, H3K27me3 decreased after 2 h, which fit the increasing expression of viral genes (Fig. 5D). However, the analysis failed to show a significant correlation between H3K27me3 and gene expression of all viral genes. We found it correlated for some genes, but in general, the level of H3K27me3 did not correlate well with gene expression (Fig. 5D). For H3K9me3, it increased at 2 h, and was dynamic at 4 h and 8 h on a subset of genes (Fig. 5E). Overall, neither of the two repressive marks showed good correlation with viral gene expression. H3K4me3 decreased on most of the genes (Fig. 5F), which does not fit its role on the host genome. All four modifications reached the lowest level on all genes at 24 h, when most of the viral DNA was packaged into capsids. Taken together, our results suggest that the histone modifications on viral genes does not correlate well with viral gene expression. An inhibitor of p300 represses HSV-1 replication and gene expression Then we investigated whether HSV-1 replication and gene expression was affected by inhibiting histone modifications. Two chemicals were evaluated: C646, an inhibitor for H3K27 acetyltransferase p300 (Bowers et al., 2010), and EPZ6438, an inhibitor for H3K27 methyltransferase EZH2 (Bate-Eya et al., 2017). The effects of these chemicals on histone modifications and their toxicity to cells were examined before further experiments (Sup. Fig. 2A & B). Surprisingly, C646 highly repressed the expression of HSV-1 genes (Fig. 6A & B), while the effects of EPZ6438 on viral gene expression were slight (Fig. 6A & C). C646 significantly repressed HSV-1 replication in THP-1 and Vero cells (Sup. Fig. 2C-G), which may be due to the repression of H3K27ac and viral gene expression. It is possible that C646 may affect 8
host gene expression, therefore we studied host gene expression patterns with RNA-Seq. Compared to the HSV-1 treated control cells, C646 treatment caused down-regulation of 2406 genes, and up-regulation of 388 genes (Fig. 6D). GO analysis showed that the up-regulated genes were not enriched with antiviral genes, while the down-regulated genes were enriched for those involved in viral processes (Fig. 6E & F). It suggests that C646 may repress HSV-1 through down-regulating viral gene expression and host genes required for viral replication. Discussion After infection, HSV-1 mRNA transcription and viral DNA replication occur in the nucleus. Multiple studies have shown that histones can bind to HSV-1 genomes, and histone modifications may regulate viral gene expression and replication. But the dynamic changes of these histone modifications across HSV-1 genomes have not been determined. In this study, we generated the landscape of four important histone modifications on HSV-1 genomes in THP-1 cells during lytic infection. H3K9me3 and H3K27me3 are two major repressive marks in mammalian cells, and H3K4me3 and H3K27ac are the most studied transcription activation marks. In total, 20 maps of histone modifications were generated, as well as the corresponding gene expression profiles. Several studies have reported that histone modifications can be controlled by histone modifying enzymes and are critical for proper viral gene expression. Our results showed the potential correlation between global changes in H3K27ac, H3K9me3 and H3K27me3, but we did not observe correlation between viral gene expression and these histone modifications. Interestingly, inhibitors of H3K27ac did repress virus replication and gene expression. This suggests that histone modifications on viral genomes may not function through regulating the transcription of individual genes. They may regulate other aspects of virus replication, such as the accessibility of viral genome regions. It will be interesting to further verify the histone modification landscapes and reveal the underlying mechanisms. We found that all four types of modified histones bind to viral DNA at immediate early stage and H3K27ac plays an important role in regulating virus replication. Inhibition of H3K27ac repressed virus replication and gene expression. To test whether it is useful to treat viral diseases through manipulation of histone modification level, we examined the function of two chemicals. EPZ6438, an 9
inhibitor for H3K27 methyltransferase EZH2 (Bate-Eya et al., 2017), had little effect on HSV-1, while C646, an inhibitor of H3K27 acetyltransferase p300 (Bowers et al., 2010; Li et al., 2019), significantly repressed HSV-1 replication and gene expression. It will be interesting to explore the potential of H3K27ac inhibitors in treating viral diseases. Although it is difficult to distinguish whether the chemical directly targets viral genomes, it is still a promising strategy to develop novel drugs to enhance the antiviral response. The enrichments of H3K27me3 and H3K9me3 appeared at the immediate early stage and then decreased on viral genomes, suggesting their potential roles in repressing viral gene expression. However, no significant correlation was observed between viral gene expression and the two modifications. H3K9me3 in mammalian cells is a mark for heterochromatin and contributes to chromatin stability (Peters et al., 2001). Lee et. al have shown that a viral protein promotes two waves of heterochromatin on one viral gene (Lee et al., 2016), indicating that the regulation of histone modifications on viral chromatin is complicated. On the other hand, an early report found γH2AX signals on viral DNA in cells (Shah and O'Shea, 2015), which we confirmed in our HSV-1 infected THP-1 cells (data not shown). γH2AX is a hallmark for the DNA damage response (DDR), but during viral infection, no signs for DDR activation were detected. H3K9me3 upregulation is connected with inhibition of DNA damage (Li et al., 2017; Peters et al., 2001). So, H3K9me3 on viral genomes may be related to stabilization of viral DNA. H3K4me3 modifications remained low during infection. In mammalian cells, H3K4me3 usually marks the transcription start sites of expressed genes, but we did not observe such effect on HSV-1 genomes. It is possible that H3K4me3 enrichment on viral genomes does not follow the rule on host genome. However, we cannot rule out the possibility that our analytic strategy is not suitable for complicated viral genomes. Our data showed that modified histones bind to HSV-1 genomes soon after infection, and the epigenetic patterns changed with time. This means it is important to investigate the dynamic changes at multiple time points when studying histone modifications on viral genomes. One simple ChIP-PCR assay at one time point may 10
not be enough to reflect the full picture. On the other hand, it still needs to be determined whether the dynamics of histone modifications are a consequence of random molecular reactions, or, at least partially, a programmed process determined by the viral genome and cellular environment. Interestingly, all four histone modifications decreased at late stages, suggesting the packaged viral DNA was free of histones. This raised new questions, such as when are histones removed from the genome?
What are the underlying mechanisms? The
resolution of these questions will greatly expand our knowledge about the life cycle of DNA viruses in cells. Materials and methods Cell lines and reagents Antibodies recognizing H3K4me3 (clone MC315, Millipore 04-745), H3K27ac (Abcam Ab4729), H3K27me3 (clone C36B11, CST 9733), H3K9me3 (Abcam ab176916), H3 (Abcam Ab1791), p300 (Abcam ab14984), β-actin (Abclonal AC026), were purchased from the indicated merchants. THP-1 and Vero cells were obtained from ATCC. THP-1 was cultured in RPMI-1640 medium (Gibco) and Vero in DMEM (Gibco), both supplemented with 10% FBS (BI). Sample preparation for transcriptomic study HSV-1 (1×108 / 107 cells) was used to infect THP-1 cells and 1 × 107 cells for each sample were used for RNA extraction. Total RNA was extracted using EASYspin RNA Mini Kit (Aidlab RN07). Briefly, tissue was triturated by trituration equipment for 20 s in lysis buffer provided by kit and then centrifuged at 12000 rpm, 4℃ for 5 min. Liquid between precipitates on the bottom and oil on the top was taken out and pipetted 10 times using 1 mL syringe. Entire volume of liquid was added into adsorption column and total RNA eluted with 50 µL RNase-free water. RNA-seq libraries were constructed by NEBNext Poly (A) mRNA Magnetic Isolation Module (NEB E7490) and NEBNext Ultra II Non-Directional RNA Second Strand Synthesis Module (NEB E6111). Briefly, poly-A mRNA was prepared with poly-T magnetic beads and transformed into cDNA with first and second strand synthesis. Newly synthesized cDNA were purified by AMPure XP beads (1:1) and eluted in 50 µL nucleotide-free water. Subsequent procedures were the same as ChIP-seq library 11
construction described previously except the sequencing depth of 20 million reads per library. RNA-seq libraries were sequenced by Illumina Hiseq X Ten platform with pair-end reads of 150 bp. Sample preparation for ChIP-Seq ChIP assay was performed as previously described (Zhu et al., 2017). HSV-1 (1×108 / 107 cells) was used to infect THP-1 cells and approximately 1×107 cells for each sample were fixed with 1% formaldehyde for 10 min and quenched by glycine. The cells were washed three times with PBS, then harvested in ChIP lysis buffer (50 mM Tris-HCl, pH7.6, 1 mM CaCl2, 0.2% Triton X-100) and incubated for 5 min with gently rotation. After centrifugation at 12000 rpm at 4℃ for 2 min, lysates were washed once by digestion buffer (50 mM Tris-HCl pH 8.0, 1 mM CaCl2, 0.2% Triton X-100). Then lysates were incubated in 630 µL digestion buffer with 1 µL MNase (NEB, M0247S) at 37℃ for 20 min and then quenched with 8 µL 0.5 M EDTA. Whole lysates were sonicated for 5 min (0.5 s on / 0.5 s off, 25% power) and the supernatants were taken out after centrifugation at 12000 rpm, 4℃ for 10 min. Immunopreciptation was performed with 150 µL sheared chromatin, 2 µg antibody, 50 µL Protein G sepharose beads and 800 µL dilution buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS) overnight at 4℃. The immunocomplexes were washed once each with Wash buffer I (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), Wash buffer II (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS) and Wash buffer III (10 mM Tris-HCl pH 8.0, 250 mM LiCl, 1 mM EDTA, 1% Na-deoxycholate, 1% NP-40), and twice with TE (10mM Tris-HCl pH 8.0, 1mM EDTA). The bound materials were eluted twice with 100 µL elution buffer (1% SDS, 0.1M NaHCO3) and 1µL Proteinase K (20 mg/mL) at room temperature for 10 min. Eluted materials were incubated at 65℃ for 6 hr and then purified with DNA purification kit (TIANGEN DP214-03). ChIP-seq libraries were constructed by VATHS Universal DNA Library Prep Kit for Illumina (Vazyme ND604). Briefly, 50 µL purified ChIP DNA (8-10 ng) was end-reparied for dA tailing, followed by adaptor ligation. Each adaptor marked with a barcode of 6 bp which can be recognized after mixing different sample together. Adaptor-ligated ChIP DNA was purified by AMPure XP beads (1:1) and then amplifying by PCR of 11-13 cycles with the primer matching with adaptor universal 12
part. Amplified ChIP DNA was purified again using AMPure XP beads (1:1) in 35 µL EB elution buffer. For multiplexing, libraries with different barcode were mixed together with equal molar quantities by considering appropriate sequencing depth (30-40 million reads per library). Libraries were sequenced by Illumina Hiseq X Ten platform with pair-end reads of 150 bp. Analysis of viral transcriptome data The sequenced reads were first quality-controlled using FASTQC software (v0.10.1) and then the adapter sequences in the reads were trimmed with Cutadapt software (v1.16). The reads were then mapped to the human hg19 reference genome along with HSV-1 reference genome (GenBank: JN555585.1) using Bowtie2 (v2.1.0) (Langmead and Salzberg, 2012) with provided annotations of human and HSV-1. Because the HSV genome has a large number of repetitive elements which can be mapped to multiple loci in the HSV genome, and bowtie2 only reports one of the best alignments, Samtools (v1.4.1) was used to screen out the reads that were uniquely mapped to the HSV-1 genome, with the parameter samtools view –b –F4 (Li et al., 2009). Bedtools (v2.25.0) was used to quantify the mapped reads across the HSV-1 genome with the parameter bedtools intersect –wa –c (Quinlan and Hall, 2010). Since the number of total reads and mapped reads varied between samples, the data were normalized by the total number of mapped reads to host genomes. To evaluate the average virus gene expression level, the normalized data were further normalized by the virus copy number of each time point. Then the bdg2bw software was used to generate bigwig format files which were finally uploaded to IGV to visualize the locations of RNA-seq reads across the HSV-1 genome. Data analysis of viral epigenome The data quality of each sample was controlled using the FASTQC tool and then the adapter sequences and low-quality sequences in the reads were trimmed with Cutadapt tool. The resulting reads were then mapped to the HSV-1 reference genome (GenBank: JN555585.1) using the Bowtie2 read mapper with default parameters and only uniquely mapped reads were kept by Samtools for further analysis. Bedtools software was used to calculate histone modifications signals on HSV-1 genome. The histone modifications were normalized by the total mapped data to the host genome and further divided by the copy number at the corresponding time point. Then the 13
bdg2bw software was used to generate bigwig format files and finally the bigwig files were uploaded to IGV to visualize the histone modifications enrichment level across the HSV-1 genome. To evaluate the viral DNA copy number in each sample, the sequencing data of ChIP input at each time point was mapped to HSV-1 genome, and then the mapped data was normalized by the mapped data size of human genome in the same sample. The calculated number represented the HSV-1 copy number. To investigate the correlation of histone modifications on HSV-1 genome, the reads count was generated in each 100-bp bin for the entire HSV-1 genome and normalized by total number of mapped reads to host genome and further divided by the copy number at the corresponding time point. The enrichment was compared between different time points and histone modifications samples for correlation analysis. To investigate the average histone modifications on a single viral genome, the enrichment of each modification was normalized by total amount of mapped reads to host cell genome, and then divided by virus copy number. To calculate the level of each histone modifications on viral genes, the total reads on each gene were added up and normalized by total number of mapped reads to host genome and further divided by the copy number. Data analysis of histone modifications on the host genome The reads were mapped to hg19 genome using the Bowtie2 tool with default parameters and only uniquely mapped reads were kept using Samtools for further analysis. Then the RPKM values were generated in each 2 kb bin for the entire hg19 genome. Such enrichment was compared between different time points and histone modifications samples for correlation analysis. The DAVID web-tool (v6.8) was used to identify the GO terms of differential expressed genes (fold change > 2) (Huang da et al., 2009). Plaque assay The supernatants of treated Vero cultures were used to infect monolayers of Vero cells. One hour later, the supernatants were removed and the infected Vero cells were washed with pre-warmed PBS twice followed by incubation with DMEM containing 2% methylcellulose for 48 h. The cells were fixed with 4% 14
paraformaldehyde for 15 min and stained with 1% crystal violet for 30 min before counting the plaques. MTT assay Vero cells were seeded at a density of 5×103 cells/well in 96-well plate and cultured 12 h. After C646 treatment, 5 µl of MTT (5 µg/ml) were added to each well, and the plate wasincubated for 4 h at 37℃. Then 100 µl of solubilization buffer (50%DNF and 30%SDS in distilled water) were added to each well, and the plate was incubated for 4 h at 37℃. After the incubation, the absorbance was measured at 570 nm in a microplate reader. Statistical analysis For all the experimental studies, the assays were repeated at least three times. At least two biological replicates were performed for deep sequencing experiments For all other experiments, at least three biological replicates were studied. Data were shown as average values ± SD and p value. Student’s t-test was used for comparison between two groups. One-way ANOVA coupled with Tukey’s post hoc test was used for comparisons over two groups. For the meta-analysis, the statistical analysis approach was described in the corresponding sections. Data access The original files of next generation sequencing are uploaded to GEO database with the following Acc. No. GSE124803. Acknowledgments This work was supported by grants from Ministry of Science and Technology of China (2016YFA0502100), National Natural Science Foundation of China to L.L. (31670874) and M.W. (31771503 and 81972647), Science and Technology Department of Hubei Province of China (CXZD2017000188).We thank Dr. Hong-Bing Shu of Wuhan University for reagents. References Bate-Eya, L.T., Gierman, H.J., Ebus, M.E., Koster, J., Caron, H.N., Versteeg, R., Dolman, M.E.M., Molenaar, J.J., 2017. Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity. Eur 15
J Cancer 75, 63-72. Bhaumik, S.R., Smith, E., Shilatifard, A., 2007. Covalent modifications of histones during development and disease pathogenesis. Nat Struct Mol Biol 14, 1008-1016. Bowers, E.M., Yan, G., Mukherjee, C., Orry, A., Wang, L., Holbert, M.A., Crump, N.T., Hazzalin, C.A., Liszczak, G., Yuan, H., Larocca, C., Saldanha, S.A., Abagyan, R., Sun, Y., Meyers, D.J., Marmorstein, R., Mahadevan, L.C., Alani, R.M., Cole, P.A., 2010. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol 17, 471-482. Brookes, E., Shi, Y., 2014. Diverse epigenetic mechanisms of human disease. Annu Rev Genet 48, 237-268. Cliffe, A.R., Garber, D.A., Knipe, D.M., 2009. Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters. J Virol 83, 8182-8190. Conn, K.L., Schang, L.M., 2013. Chromatin dynamics during lytic infection with herpes simplex virus 1. Viruses 5, 1758-1786. Harkness, J.M., Kader, M., DeLuca, N.A., 2014. Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells. J Virol 88, 6847-6861. Henikoff, S., Shilatifard, A., 2011. Histone modification: cause or cog? Trends Genet 27, 389-396. Hill, J.M., Quenelle, D.C., Cardin, R.D., Vogel, J.L., Clement, C., Bravo, F.J., Foster, T.P., Bosch-Marce, M., Raja, P., Lee, J.S., Bernstein, D.I., Krause, P.R., Knipe, D.M., Kristie, T.M., 2014. Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes. Science translational medicine 6, 265ra169. Hilton, I.B., Simon, J.M., Lieb, J.D., Davis, I.J., Damania, B., Dittmer, D.P., 2013. The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus. J Virol 87, 11831-11842. Huang da, W., Sherman, B.T., Lempicki, R.A., 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57. James, S.H., Kimberlin, D.W., 2015. Neonatal Herpes Simplex Virus Infection. Infectious disease clinics of North America 29, 391-400. Kent, J.R., Zeng, P.Y., Atanasiu, D., Gardner, J., Fraser, N.W., Berger, S.L., 2004. During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J Virol 78, 10178-10186. Kristie, T.M., 2015. Dynamic modulation of HSV chromatin drives initiation of infection and provides targets for epigenetic therapies. Virology 479-480, 555-561. Lacasse, J.J., Schang, L.M., 2012. Herpes simplex virus 1 DNA is in unstable nucleosomes throughout the lytic infection cycle, and the instability of the nucleosomes is independent of DNA replication. J Virol 86, 11287-11300. Langmead, B., Salzberg, S.L., 2012. Fast gapped-read alignment with Bowtie 2. Nature methods 9, 357-359. Lee, J.S., Raja, P., Knipe, D.M., 2016. Herpesviral ICP0 Protein Promotes Two Waves of Heterochromatin Removal on an Early Viral Promoter during Lytic Infection. mBio 7, 16
e02007-02015. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., Genome Project Data Processing, S., 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079. Li, Q.L., Lei, P.J., Zhao, Q.Y., Li, L., Wei, G., Wu, M., 2017. Epigenomic analysis in a cell-based model reveals the roles of H3K9me3 in breast cancer transformation. Epigenomics 9, 1077-1092. Li, Q.L., Wang, D.Y., Ju, L.G., Yao, J., Gao, C., Lei, P.J., Li, L.Y., Zhao, X.L., Wu, M., 2019. The hyper-activation of transcriptional enhancers in breast cancer. Clinical epigenetics 11, 48. Liang, Y., Vogel, J.L., Narayanan, A., Peng, H., Kristie, T.M., 2009. Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat Med 15, 1312-1317. Medina-Rivera, A., Santiago-Algarra, D., Puthier, D., Spicuglia, S., 2018. Widespread Enhancer Activity from Core Promoters. Trends Biochem Sci 43, 452-468. Oh, J., Sanders, I.F., Chen, E.Z., Li, H., Tobias, J.W., Isett, R.B., Penubarthi, S., Sun, H., Baldwin, D.A., Fraser, N.W., 2015. Genome wide nucleosome mapping for HSV-1 shows nucleosomes are deposited at preferred positions during lytic infection. PLoS One 10, e0117471. Peters, A.H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schofer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., Opravil, S., Doyle, M., Sibilia, M., Jenuwein, T., 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107, 323-337. Quinlan, A.R., Hall, I.M., 2010. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842. Rickels, R., Shilatifard, A., 2018. Enhancer Logic and Mechanics in Development and Disease. Trends Cell Biol 28, 608-630. Shah, G.A., O'Shea, C.C., 2015. Viral and Cellular Genomes Activate Distinct DNA Damage Responses. Cell 162, 987-1002. Sun, R., Tan, X., Wang, X., Wang, X., Yang, L., Robertson, E.S., Lan, K., 2017. Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues. PLoS Pathog 13, e1006167. Thellman, N.M., Triezenberg, S.J., 2017. Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency. Pathogens 6. Toth, Z., Brulois, K., Jung, J.U., 2013. The chromatin landscape of Kaposi's sarcoma-associated herpesvirus. Viruses 5, 1346-1373. Toth, Z., Maglinte, D.T., Lee, S.H., Lee, H.R., Wong, L.Y., Brulois, K.F., Lee, S., Buckley, J.D., Laird, P.W., Marquez, V.E., Jung, J.U., 2010. Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog 6, e1001013. Whitley, R.J., Roizman, B., 2001. Herpes simplex virus infections. Lancet 357, 1513-1518. Zhu, K., Lei, P.J., Ju, L.G., Wang, X., Huang, K., Yang, B., Shao, C., Zhu, Y., Wei, G., Fu, X.D., Li, L., Wu, M., 2017. SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing. Nucleic Acids Res 45, 92-105. 17
18
Figure legends Fig. 1 Enrichment of histone modifications on HSV-1 genomes in THP-1 cells. (A-D) THP-1 cells were infected with HSV-1 and 1 h later, cells were harvested and ChIP assay was performed. The histone modifications on viral gB gene, H3K9me3 (A), H3K27me3 (B), H3K27ac (C) and H3K4me3 (D), were measured with quantitative PCR. The host gene GAPDH was a negative control for H3K9me3 and H3K27me3, and a positive control for H3K27ac and H3K4me3. The host gene MYT1 was a positive control for H3K9me3 and H3K27me3. The host centromere region in chromosome 7 was a negative control for H3K27ac and H3K4me3. (E-H) THP-1 cells were infected with HSV-1 and harvested at the indicated time points. H3K9me3 (E), H3K27me3 (F), H3K27ac (G) and H3K4me3 (H) on gB were measured with ChIP assay. * means p value < 0.05; ** means p value < 0.01; NS, non-significant. Fig. 2 The dynamic gene expression of HSV-1 in THP-1 cells. (A) The reads count of RNA-Seq data on HSV-1 genome at each time point. (B) HSV-1 Copy number at each time point, represented by the ratio of the nucleotide base number of input sequences mapped to HSV-1 genome divided by the size of HSV-1 genome. The nucleotide base number was normalized to the mapping number of host genome. (C) The relative reads count of H3K27ac, H3K27me3, H3K4me3, H3K9me3 and Input samples on HSV-1 genomes at different time points, which were normalized to the host cell genome and the corresponding value at 1 h, which represents the average value in each cell. (D) Distribution of RNA-seq reads across the HSV-1 genome at each time point. The locations of reads for each time point were shown relative to a map of the mRNA for each HSV-1 gene. The average mRNA level of single virus was shown after normalization to the number of host mapped reads and relative copy number. The structure and coding genes of HSV-1 reference genome are shown at the bottom of the figure. Fig. 3 The dynamic epigenomic landscapes of histone modifications of HSV-1. (A - D) H3K9me3 (A), H3K27me3 (B), H3K4me3 (C) and H3K27ac (D) on HSV-1 genome at different time points. The y axis represents the enrichment of modifications on HSV-1 genome, which was shown by the reads number normalized by the host mapped reads and virus copy number at the corresponding time points.
19
Fig. 4 The dynamics of H3K27ac, H3K27me3, H3K4me3 and H3K9me3 during the infection process. (A & B) The average level of gene expression (A) and histone modifications (B) of each HSV-1 virus. The y-axis represents the normalized mapped read number of RNA or histone modifications normalized by the number of host genome and relative viral genome in the input sample at each time point, which represents the average value of each virus. (C) The Spearman’s correlation of histone modifications on human genome (hg19). The colors represent the rate of correlation. (D) The Spearman’s correlation of histone modifications on HSV-1 genome. Fig. 5 The association of histone modifications and viral gene expression. (A) The gene expression level of all HSV-1 genes at 1 h, 2 h, 4 h, 8 h and 24 h after infection. The RNA level of each gene was calculated by adding up all reads on the gene body and normalized with the corresponding host mapped reads and the relative copy number. The change of gene expression at different time points was shown with Z score. (B) Heat maps to show the enrichment of H3K27ac on all HSV-1 genes. The values of the indicated histone modifications were calculated by adding up all reads on the gene body, and normalized with the corresponding mapped reads to host genome and the relative virus copy number. The change of histone modification in each row was shown with Z score. (C) Scatterplots showing relationships between mRNA and H3K27ac on all HSV-1 genes. Pearson correlations and p values are indicated. Linear models are shown as black line. (D-F) Heat maps to show the enrichment of H3K27me3 (D) and H3K9me3 (E) and H3K4me3 (F) on all HSV-1 genes. Data were analyzed as that in (B). Fig.6 The anti-viral functions of epigenetic inhibitor C646. (A) The normalized gene expression level of HSV-1 in THP-1 treated with C646, DMSO and EPZ6438. The Y axis represents the number of all the mapped HSV-1 reads, normalized by the mapped total RNA reads to host genomes and divided by the length of the viral genome. (B & C) Distribution of RNA-seq reads across the HSV-1 genome treated with C646 (B) or EPZ6438 (C). The scales of the graphs were normalized to the number of total mapped reads. (D) The differential expressed genes after C646 treatment. Up-regulated genes were labeled in red and down-regulated genes in green. (E & F)The gene ontology and pathway analysis of the up-regulated genes (E) and down-regulated genes (F). 20
Highlights 1. Histone modifications on viral genome is tightly controlled and change rapidly. 2. H3K27ac gradually increases along with virus life cycle. 3. H3K27me3 and H3K9me3 are enriched at the early stage and decreases during infection. 4. A chemical inhibitor of H3K27ac greatly repressed HSV-1 replication.
S0166-3542(19)30334-1
DOI:
https://doi.org/10.1016/j.antiviral.2020.104730
Reference:
AVR 104730
To appear in:
Antiviral Research
Received Date: 11 June 2019 Revised Date:
23 December 2019
Accepted Date: 28 January 2020
Please cite this article as: Chuan, G., Chen, L., Tang, S.-B., Long, Q.-Y., He, J.-L., Zhang, N.A., Shu, H.-B., Chen, Z.-X., Wu, M., Li, L.-Y., The epigenetic landscapes of histone modifications on HSV-1 genome in human THP-1 cells, Antiviral Research (2020), doi: https://doi.org/10.1016/ j.antiviral.2020.104730. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier B.V.
The epigenetic landscapes of histone modifications on HSV-1 genome in human THP-1 cells Gao Chuan1, *, Lin Chen1, *, Shan-Bo Tang1, *, Qiao-Yun Long1, *, Jia-Li He1, Na-An Zhang2, Hong-Bing Shu3, Zhen-Xia Chen2, Min Wu1, #, Lian-Yun Li1, #
1
Hubei Key Laboratory of Cell Homeostasis, Hubei Key Laboratory of
Developmentally Originated Disease, Hubei Key Laboratory of Enteropathy, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China 2
College of Life Sciences and Technology, Huazhong Agriculture University, Wuhan,
Hubei 430070, China 3
Medical Research Institute, College of Life Sciences, Wuhan University, Wuhan,
Hubei 430072, China *
Equal contribution to the study.
Contact information #
Correspondence should be addressed to Dr. Lian-Yun Li, Email:
[email protected], Tel: 86-27-68756672; or Dr. Min Wu, Email: [email protected], Tel: 86-27-68756620 Running title HSV-1 epigenome in THP-1 cells
1
Abstract Histone positioning and modifications on viral genomes are important factors regulating virus replication. To investigate the dynamics of modified histones on the viral genome and their potential roles in antiviral response, we studied the dynamic changes of histone modifications across the HSV-1 genome in THP-1 cells. Histone modifications were detected on the HSV-1 genome soon after infection, including H3K9me3, H3K27me3, H3K4me3 and H3K27ac. These modifications emerged on the viral genome soon after infection and changed rapidly along with virus life cycle progression. The transcription repression marks, H3K9me3 and H3K27me3, decreased on the viral genome during the infection process; the transcription activation mark H3K27ac increased. Treatment with C646, an inhibitor of H3K27ac transferase p300, significantly repressed virus replication and viral gene expression. Our study reveals the relationship between histone modifications and viral gene expression and provides potential novel strategies for antiviral treatment. Key words HSV-1, epigenome, H3K9me3, H3K27me3, H3K27ac, H3K4me3
2
Introduction Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) are members of the herpesvirus family, and HSV-1 is often used as a model organism to study innate immunity against DNA viruses. During lytic infection, HSV-1 usually causes only mild symptoms. However, HSV-1 hides from the immune system in nerve cells (James and Kimberlin, 2015; Thellman and Triezenberg, 2017; Whitley and Roizman, 2001) and leads to latent infection. After entry into cells, HSV-1 injects its genomic DNA into the nucleus, where viral genes are transcribed and the viral genome is replicated. Viral genes are expressed in an ordered pattern of immediate-early (IE), early (E) and late (L) genes (Harkness et al., 2014; Thellman and Triezenberg, 2017; Whitley and Roizman, 2001). A major question in the field is how the ordered expression of these genes is organized and regulated. Histones bind to the viral genome soon after viral DNA enters the nucleus. It is not clear whether the presence of histones and their modifications benefit the ordered viral gene expression and life cycle, or whether they are involved in innate immunity. It has been well demonstrated that histone modifications are critical epigenetic factors in regulating mammalian gene expression (Henikoff and Shilatifard, 2011). H3K9me3 and H3K27me3 are typical repressive marks; H3K4me3 is usually associated with active transcription (Brookes and Shi, 2014; Rickels and Shilatifard, 2018). H3K27ac is another hallmark for actively transcribed genes, which is catalyzed by histone acetyltransferase p300/CBP. It occupies the promoter of active genes, and recently was shown to mark active enhancers (Medina-Rivera et al., 2018; Rickels and Shilatifard, 2018). However, it has been debated whether histones stably bind to HSV-1 genomes and form viral chromatin. Early studies showed that the interaction between histones and viral DNA is weak, based on enzyme digestion assay, suggesting it is unlikely that stable chromatin forms similar to mammalian chromatin (Bhaumik et al., 2007; Kent et al., 2004; Lacasse and Schang, 2012). Later, multiple studies showed that histones, including typical histone modifications, are repeatedly detected on viral genomes, mostly though Chromatin Immunoprecipitation (ChIP) assays (Conn and Schang, 2013; Kristie, 2015; Lacasse and Schang, 2012; Oh et al., 2015). It was reported that formation of heterochromatin marks on HSV-1 genome is critical for ordered gene expression (Cliffe et al., 2009). Inhibition of LSD1, a histone H3K4 demethylase, results in heterochromatic suppression of the HSV-1 genome and subsequently affects viral infection (Hill et al., 2014; Liang et al., 2009). The 3
immediate early gene ICP0 removes heterochromatin marks H3K9me3 and H3K27me3 from viral gene promoters during lytic infection (Lee et al., 2016). Along with the application of epigenomic approaches in viral studies, the epigenomic landscapes of the HSV-1 genome, as well as that of some other viruses, have been elucidated. A recent study mapped the nucleosome positions on HSV-1 genome via high throughput sequencing (Oh et al., 2015). The landscape of histone modifications, including H3K4me3, H3K27me3 and H3K27ac on KHSV genome was also reported in vitro and in vivo (Hilton et al., 2013; Sun et al., 2017; Toth et al., 2013; Toth et al., 2010). However, since the order of HSV-1 gene expression is tightly controlled (Harkness et al., 2014), the epigenetic marks must change dynamically. Therefore, the dynamic epigenetic landscapes of viral genomes after infection should be determined to demonstrate the epigenetic regulation of viral gene expression. In the current study, we investigated the dynamic epigenetic landscape on HSV-1 genomes and explored the potential for a novel antiviral strategy. We provided epigenomic evidence to show that the histone modifications on HSV-1 genomes emerged soon after infection and were highly dynamic during lytic infection. Chemical inhibition of H3K27ac significantly inhibited HSV-1 gene expression and replication, which points out the important role of histone modifications for virus replication and gene expression and suggests a novel strategy for antiviral treatment. Results Histone modifications bound on viral genome soon after infection The occurrence of modified histones on the viral genome was confirmed by ChIP-PCR. THP-1 is a monocyte leukemia cell line and is often used for innate immune studies of DNA and RNA viruses. THP-1 cells were infected with HSV-1 for 1 h and four modifications were studied, including H3K27ac and H3K4me3 for active transcription, and H3K9me3 and H3K27me3 for repressive transcription. Both H3K9me3 and H3K27me3 were easily detected on the gB gene (Fig. 1A & B). The highly expressed host gene GAPDH was a negative control. The transcriptionally repressed host gene MYT1 was a positive control. The H3K9me3 enrichment on gB was comparable to that on MYT1 (Fig. 1A), while H3K27me3 was relatively lower (Fig. 1B). The active gene marks, H3K4me3 and H3K27ac were detected on gB 1 h after infection (Fig. 1C & D), which were lower than the GAPDH positive control and higher than the negative control (the centromere of chromosome 7) (Fig. 1C & D), 4
suggesting the active marks were present at a low level. The enrichment of H3K27ac and H3K4me3 was also measured in Vero cells, which showed a similar pattern as in THP-1 (Sup. Fig. 1). Then we collected cells at different time points after infection, and analyzed the dynamics of histone modifications on gB. Both repressive marks, H3K9me3 and H3K27me3, were highest at the early stage of infection and gradually decreased with time (Fig. 1E & F); the transcription activation mark, H3K27ac was lowest at 1 h and 2 h, then increased later (Fig. 1G). Interestingly, another activation mark, H3K4me3, did not change and maintained a low level (Fig. 1H). Experimental design and data quality for epigenomic study of HSV-1 genome To study the dynamic epigenetic landscape of histone modifications on HSV-1 genomes during lytic replication, we used HSV-1 (MOI = 0.5) to infect THP-1 cells, and collected samples at 1 h, 2 h, 4 h, 8 h and 24 h after infection. The cells were then subjected to RNA-Seq and ChIP-Seq with antibodies recognizing H3K27ac, H3K4me3, H3K9me3 and H3K27me3. Two biological replicates were performed for each sequencing, and data quality control was done before analysis. We found that only a few reads from early time points (1 h and 2 h) were mapped to the HSV-1 genome, probably due to the low copy number of virus. Therefore, we increased the sequencing depth to ensure enough HSV-1 specific data was analyzed. The informatics analysis was then performed with the average level of each modification. During analysis, we found the sequencing depth of some H3K9me3 samples was not equivalent to others in the same experiment, so to ensure the quality of our analysis, we performed another replicate for H3K9me3 and used the average value of three replicates for further study. The dynamic expression pattern of HSV-1 genes The data were mapped to the HSV-1 genome sequence (GenBank Acc: JN555585.1), and since the amount of host cell genome is constant, we used the ratio of the mapped viral sequences to the host genome sequence to represent the average amount of virus DNA in each cell. Viral gene expression was very low at 1 h and 2 h after infection, increased slowly at 4 h to 8 h, and reached a high level at 24 h (Fig. 2A). Since the level of gene expression varied for different viral genes, and the total expression level of host genes was more stable, we normalized the viral RNA with the total human RNA to calculate the expression level of viral genes in each cell. The 5
change in viral gene expression levels reflected the change in DNA copy number: low at 1 h and 2 h, increasing at 4 h, and reaching high levels at 8 h and 24 h (Fig. 2B). Then we normalized the modifications on the viral genome with the human genome to study their average levels in each cell, which again reflected the trends of viral DNA copy number and RNA level (Fig. 2C). These results suggest that the ChIP-Seq signals we detected were probably real signals on the virus genome. The relative reads count of input reflected the increase of viral DNA amount, while the distance between each modification to input samples may reflect the change of enrichment for each modification on viral genomes (Fig. 2C). For instance, H3K27ac level was close to the input amount at 1 h, then rose higher than input at 8 h and 24 h, which means the average H3K27ac level kept increasing on viral genomes (Fig. 2C). To assess the average gene expression level per virus, the normalized RNA-Seq results were further divided by the corresponding ratio of viral copy number; and the dynamic maps of HSV-1 gene expression patterns were generated for different time points, which were similar to a previous report (Fig. 2D) (Harkness et al., 2014), suggesting that our sequencing data were reliable. The patterns of histone modifications on HSV-1 genome Then we analyzed the ChIP-Seq data of four histone modifications and generated their landscapes on the HSV-1 genome at different time points (Fig. 3A-D). We normalized the histone modification data by the relative viral DNA amount, and the results represent the average level of histone modifications on each viral genome. Obvious signals for all four modifications were detected at 1 h after infection, which means HSV-1 DNA was rapidly packaged with modified histones after entering the nucleus (Fig. 3A-D). As time elapsed, the signals for all four histone modifications on HSV-1 genomes changed rapidly. H3K9me3 emerged immediately at 1 h, increased at 2 h and 4 h, then decreased at 8 h (Fig. 3A). The level of H3K27me3 was at high at 1 h and 2 h, and then decreased slowly from 4 h (Fig. 3B). H3K4me3 emerged at 1 h and remained at the same level until 4 h, and then decreased slightly at 8 h (Fig. 3C). H3K27ac was the most dynamic mark. It emerged at 1 h, remained low at 2 h and 4 h, and then increased dramatically at 8 h (Fig. 3D). The signals at early time points (1 h to 8 h) nearly disappeared at 24 h (Fig. 3A-D). The low signals at 24 h do not mean that virus genomes were not modified by histones, since high levels of histone 6
modifications were detected earlier (Fig. 2C). Interestingly, the average gene expression level was low (Fig. 2D), suggesting correlation existed with histone binding. The dynamic changes of the global signals of histone modifications on HSV-1 and host genomes To study the potential functions of these modifications on viral gene expression, we analyzed the dynamic trends for the enrichment of histone modifications on viral genomes. A line diagram was drawn to show the dynamics of each histone modification on viral genomes, as well as the corresponding viral gene expression (Fig. 4A & B). Similar to the results shown in Fig. 3, H3K27ac increased from 4 h to 8 h, while H3K4me3, H3K9me3 and H3K27me3 slowly decreased on viral genomes. To evaluate the consistency of each histone modification on viral genomes, we analyzed their correlation over time. Although HSV-1 expression induced a significant change of gene expression, the correlations of each histone modification among different time points were high, indicating that the epigenetic landscapes on host genome did not change much after infection (Fig. 4C). A relative high correlation between H3K9me3 and H3K27me3 was also observed, probably due to the transcriptional repressive abilities of these two modifications (Fig. 4C). However, the HSV-1 epigenome was different. The correlations among different time points of all four modifications were low (Fig. 4D). Since the expression of viral genes is tightly controlled, the change of these modifications may play important roles during virus infection. The dynamic change of histone modifications on HSV-1 genes To evaluate the correlation between histone modifications and expression of single genes, we calculated the expression level of one gene by adding up all the reads mapped to it, and then normalized by the number of mapped reads to host genome and the corresponding virus DNA amount. Since the HSV-1 coding sequences overlapped (Fig. 2 & 3 bottom), our strategy could not determine the exact expression level and histone modifications of all viral genes. A heat map was generated to show the expression of each viral gene (Fig. 5A), and we generated heat maps for histone modifications of the corresponding gene (Fig. 5B - F). On the genome of eukaryote 7
species, H3K4me3 usually marks transcription start sites (TSS) and H3K27ac usually marks promoters and enhancers. H3K9me3 and H3K27me3 cover the promoters and coding sequences of repressed genes. Among the four modifications, H3K27ac on individual genes was synchronized, supporting it as one of the critical histone modifications for virus (Fig. 5B & C). Though the correlation between H3K27ac and gene expression level was greater than other modifications (Fig. 5C), the 4 h and 8 h results deviated from the trend line, suggesting that the levels of H3K27ac on viral genes does not correlate well with the transcription levels of individual genes. H3K9me3 and H3K27me3 emerged on many viral genes at 1 h, and then peaked at 2 h (Fig. 5D & E). On most genes, H3K27me3 decreased after 2 h, which fit the increasing expression of viral genes (Fig. 5D). However, the analysis failed to show a significant correlation between H3K27me3 and gene expression of all viral genes. We found it correlated for some genes, but in general, the level of H3K27me3 did not correlate well with gene expression (Fig. 5D). For H3K9me3, it increased at 2 h, and was dynamic at 4 h and 8 h on a subset of genes (Fig. 5E). Overall, neither of the two repressive marks showed good correlation with viral gene expression. H3K4me3 decreased on most of the genes (Fig. 5F), which does not fit its role on the host genome. All four modifications reached the lowest level on all genes at 24 h, when most of the viral DNA was packaged into capsids. Taken together, our results suggest that the histone modifications on viral genes does not correlate well with viral gene expression. An inhibitor of p300 represses HSV-1 replication and gene expression Then we investigated whether HSV-1 replication and gene expression was affected by inhibiting histone modifications. Two chemicals were evaluated: C646, an inhibitor for H3K27 acetyltransferase p300 (Bowers et al., 2010), and EPZ6438, an inhibitor for H3K27 methyltransferase EZH2 (Bate-Eya et al., 2017). The effects of these chemicals on histone modifications and their toxicity to cells were examined before further experiments (Sup. Fig. 2A & B). Surprisingly, C646 highly repressed the expression of HSV-1 genes (Fig. 6A & B), while the effects of EPZ6438 on viral gene expression were slight (Fig. 6A & C). C646 significantly repressed HSV-1 replication in THP-1 and Vero cells (Sup. Fig. 2C-G), which may be due to the repression of H3K27ac and viral gene expression. It is possible that C646 may affect 8
host gene expression, therefore we studied host gene expression patterns with RNA-Seq. Compared to the HSV-1 treated control cells, C646 treatment caused down-regulation of 2406 genes, and up-regulation of 388 genes (Fig. 6D). GO analysis showed that the up-regulated genes were not enriched with antiviral genes, while the down-regulated genes were enriched for those involved in viral processes (Fig. 6E & F). It suggests that C646 may repress HSV-1 through down-regulating viral gene expression and host genes required for viral replication. Discussion After infection, HSV-1 mRNA transcription and viral DNA replication occur in the nucleus. Multiple studies have shown that histones can bind to HSV-1 genomes, and histone modifications may regulate viral gene expression and replication. But the dynamic changes of these histone modifications across HSV-1 genomes have not been determined. In this study, we generated the landscape of four important histone modifications on HSV-1 genomes in THP-1 cells during lytic infection. H3K9me3 and H3K27me3 are two major repressive marks in mammalian cells, and H3K4me3 and H3K27ac are the most studied transcription activation marks. In total, 20 maps of histone modifications were generated, as well as the corresponding gene expression profiles. Several studies have reported that histone modifications can be controlled by histone modifying enzymes and are critical for proper viral gene expression. Our results showed the potential correlation between global changes in H3K27ac, H3K9me3 and H3K27me3, but we did not observe correlation between viral gene expression and these histone modifications. Interestingly, inhibitors of H3K27ac did repress virus replication and gene expression. This suggests that histone modifications on viral genomes may not function through regulating the transcription of individual genes. They may regulate other aspects of virus replication, such as the accessibility of viral genome regions. It will be interesting to further verify the histone modification landscapes and reveal the underlying mechanisms. We found that all four types of modified histones bind to viral DNA at immediate early stage and H3K27ac plays an important role in regulating virus replication. Inhibition of H3K27ac repressed virus replication and gene expression. To test whether it is useful to treat viral diseases through manipulation of histone modification level, we examined the function of two chemicals. EPZ6438, an 9
inhibitor for H3K27 methyltransferase EZH2 (Bate-Eya et al., 2017), had little effect on HSV-1, while C646, an inhibitor of H3K27 acetyltransferase p300 (Bowers et al., 2010; Li et al., 2019), significantly repressed HSV-1 replication and gene expression. It will be interesting to explore the potential of H3K27ac inhibitors in treating viral diseases. Although it is difficult to distinguish whether the chemical directly targets viral genomes, it is still a promising strategy to develop novel drugs to enhance the antiviral response. The enrichments of H3K27me3 and H3K9me3 appeared at the immediate early stage and then decreased on viral genomes, suggesting their potential roles in repressing viral gene expression. However, no significant correlation was observed between viral gene expression and the two modifications. H3K9me3 in mammalian cells is a mark for heterochromatin and contributes to chromatin stability (Peters et al., 2001). Lee et. al have shown that a viral protein promotes two waves of heterochromatin on one viral gene (Lee et al., 2016), indicating that the regulation of histone modifications on viral chromatin is complicated. On the other hand, an early report found γH2AX signals on viral DNA in cells (Shah and O'Shea, 2015), which we confirmed in our HSV-1 infected THP-1 cells (data not shown). γH2AX is a hallmark for the DNA damage response (DDR), but during viral infection, no signs for DDR activation were detected. H3K9me3 upregulation is connected with inhibition of DNA damage (Li et al., 2017; Peters et al., 2001). So, H3K9me3 on viral genomes may be related to stabilization of viral DNA. H3K4me3 modifications remained low during infection. In mammalian cells, H3K4me3 usually marks the transcription start sites of expressed genes, but we did not observe such effect on HSV-1 genomes. It is possible that H3K4me3 enrichment on viral genomes does not follow the rule on host genome. However, we cannot rule out the possibility that our analytic strategy is not suitable for complicated viral genomes. Our data showed that modified histones bind to HSV-1 genomes soon after infection, and the epigenetic patterns changed with time. This means it is important to investigate the dynamic changes at multiple time points when studying histone modifications on viral genomes. One simple ChIP-PCR assay at one time point may 10
not be enough to reflect the full picture. On the other hand, it still needs to be determined whether the dynamics of histone modifications are a consequence of random molecular reactions, or, at least partially, a programmed process determined by the viral genome and cellular environment. Interestingly, all four histone modifications decreased at late stages, suggesting the packaged viral DNA was free of histones. This raised new questions, such as when are histones removed from the genome?
What are the underlying mechanisms? The
resolution of these questions will greatly expand our knowledge about the life cycle of DNA viruses in cells. Materials and methods Cell lines and reagents Antibodies recognizing H3K4me3 (clone MC315, Millipore 04-745), H3K27ac (Abcam Ab4729), H3K27me3 (clone C36B11, CST 9733), H3K9me3 (Abcam ab176916), H3 (Abcam Ab1791), p300 (Abcam ab14984), β-actin (Abclonal AC026), were purchased from the indicated merchants. THP-1 and Vero cells were obtained from ATCC. THP-1 was cultured in RPMI-1640 medium (Gibco) and Vero in DMEM (Gibco), both supplemented with 10% FBS (BI). Sample preparation for transcriptomic study HSV-1 (1×108 / 107 cells) was used to infect THP-1 cells and 1 × 107 cells for each sample were used for RNA extraction. Total RNA was extracted using EASYspin RNA Mini Kit (Aidlab RN07). Briefly, tissue was triturated by trituration equipment for 20 s in lysis buffer provided by kit and then centrifuged at 12000 rpm, 4℃ for 5 min. Liquid between precipitates on the bottom and oil on the top was taken out and pipetted 10 times using 1 mL syringe. Entire volume of liquid was added into adsorption column and total RNA eluted with 50 µL RNase-free water. RNA-seq libraries were constructed by NEBNext Poly (A) mRNA Magnetic Isolation Module (NEB E7490) and NEBNext Ultra II Non-Directional RNA Second Strand Synthesis Module (NEB E6111). Briefly, poly-A mRNA was prepared with poly-T magnetic beads and transformed into cDNA with first and second strand synthesis. Newly synthesized cDNA were purified by AMPure XP beads (1:1) and eluted in 50 µL nucleotide-free water. Subsequent procedures were the same as ChIP-seq library 11
construction described previously except the sequencing depth of 20 million reads per library. RNA-seq libraries were sequenced by Illumina Hiseq X Ten platform with pair-end reads of 150 bp. Sample preparation for ChIP-Seq ChIP assay was performed as previously described (Zhu et al., 2017). HSV-1 (1×108 / 107 cells) was used to infect THP-1 cells and approximately 1×107 cells for each sample were fixed with 1% formaldehyde for 10 min and quenched by glycine. The cells were washed three times with PBS, then harvested in ChIP lysis buffer (50 mM Tris-HCl, pH7.6, 1 mM CaCl2, 0.2% Triton X-100) and incubated for 5 min with gently rotation. After centrifugation at 12000 rpm at 4℃ for 2 min, lysates were washed once by digestion buffer (50 mM Tris-HCl pH 8.0, 1 mM CaCl2, 0.2% Triton X-100). Then lysates were incubated in 630 µL digestion buffer with 1 µL MNase (NEB, M0247S) at 37℃ for 20 min and then quenched with 8 µL 0.5 M EDTA. Whole lysates were sonicated for 5 min (0.5 s on / 0.5 s off, 25% power) and the supernatants were taken out after centrifugation at 12000 rpm, 4℃ for 10 min. Immunopreciptation was performed with 150 µL sheared chromatin, 2 µg antibody, 50 µL Protein G sepharose beads and 800 µL dilution buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS) overnight at 4℃. The immunocomplexes were washed once each with Wash buffer I (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), Wash buffer II (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS) and Wash buffer III (10 mM Tris-HCl pH 8.0, 250 mM LiCl, 1 mM EDTA, 1% Na-deoxycholate, 1% NP-40), and twice with TE (10mM Tris-HCl pH 8.0, 1mM EDTA). The bound materials were eluted twice with 100 µL elution buffer (1% SDS, 0.1M NaHCO3) and 1µL Proteinase K (20 mg/mL) at room temperature for 10 min. Eluted materials were incubated at 65℃ for 6 hr and then purified with DNA purification kit (TIANGEN DP214-03). ChIP-seq libraries were constructed by VATHS Universal DNA Library Prep Kit for Illumina (Vazyme ND604). Briefly, 50 µL purified ChIP DNA (8-10 ng) was end-reparied for dA tailing, followed by adaptor ligation. Each adaptor marked with a barcode of 6 bp which can be recognized after mixing different sample together. Adaptor-ligated ChIP DNA was purified by AMPure XP beads (1:1) and then amplifying by PCR of 11-13 cycles with the primer matching with adaptor universal 12
part. Amplified ChIP DNA was purified again using AMPure XP beads (1:1) in 35 µL EB elution buffer. For multiplexing, libraries with different barcode were mixed together with equal molar quantities by considering appropriate sequencing depth (30-40 million reads per library). Libraries were sequenced by Illumina Hiseq X Ten platform with pair-end reads of 150 bp. Analysis of viral transcriptome data The sequenced reads were first quality-controlled using FASTQC software (v0.10.1) and then the adapter sequences in the reads were trimmed with Cutadapt software (v1.16). The reads were then mapped to the human hg19 reference genome along with HSV-1 reference genome (GenBank: JN555585.1) using Bowtie2 (v2.1.0) (Langmead and Salzberg, 2012) with provided annotations of human and HSV-1. Because the HSV genome has a large number of repetitive elements which can be mapped to multiple loci in the HSV genome, and bowtie2 only reports one of the best alignments, Samtools (v1.4.1) was used to screen out the reads that were uniquely mapped to the HSV-1 genome, with the parameter samtools view –b –F4 (Li et al., 2009). Bedtools (v2.25.0) was used to quantify the mapped reads across the HSV-1 genome with the parameter bedtools intersect –wa –c (Quinlan and Hall, 2010). Since the number of total reads and mapped reads varied between samples, the data were normalized by the total number of mapped reads to host genomes. To evaluate the average virus gene expression level, the normalized data were further normalized by the virus copy number of each time point. Then the bdg2bw software was used to generate bigwig format files which were finally uploaded to IGV to visualize the locations of RNA-seq reads across the HSV-1 genome. Data analysis of viral epigenome The data quality of each sample was controlled using the FASTQC tool and then the adapter sequences and low-quality sequences in the reads were trimmed with Cutadapt tool. The resulting reads were then mapped to the HSV-1 reference genome (GenBank: JN555585.1) using the Bowtie2 read mapper with default parameters and only uniquely mapped reads were kept by Samtools for further analysis. Bedtools software was used to calculate histone modifications signals on HSV-1 genome. The histone modifications were normalized by the total mapped data to the host genome and further divided by the copy number at the corresponding time point. Then the 13
bdg2bw software was used to generate bigwig format files and finally the bigwig files were uploaded to IGV to visualize the histone modifications enrichment level across the HSV-1 genome. To evaluate the viral DNA copy number in each sample, the sequencing data of ChIP input at each time point was mapped to HSV-1 genome, and then the mapped data was normalized by the mapped data size of human genome in the same sample. The calculated number represented the HSV-1 copy number. To investigate the correlation of histone modifications on HSV-1 genome, the reads count was generated in each 100-bp bin for the entire HSV-1 genome and normalized by total number of mapped reads to host genome and further divided by the copy number at the corresponding time point. The enrichment was compared between different time points and histone modifications samples for correlation analysis. To investigate the average histone modifications on a single viral genome, the enrichment of each modification was normalized by total amount of mapped reads to host cell genome, and then divided by virus copy number. To calculate the level of each histone modifications on viral genes, the total reads on each gene were added up and normalized by total number of mapped reads to host genome and further divided by the copy number. Data analysis of histone modifications on the host genome The reads were mapped to hg19 genome using the Bowtie2 tool with default parameters and only uniquely mapped reads were kept using Samtools for further analysis. Then the RPKM values were generated in each 2 kb bin for the entire hg19 genome. Such enrichment was compared between different time points and histone modifications samples for correlation analysis. The DAVID web-tool (v6.8) was used to identify the GO terms of differential expressed genes (fold change > 2) (Huang da et al., 2009). Plaque assay The supernatants of treated Vero cultures were used to infect monolayers of Vero cells. One hour later, the supernatants were removed and the infected Vero cells were washed with pre-warmed PBS twice followed by incubation with DMEM containing 2% methylcellulose for 48 h. The cells were fixed with 4% 14
paraformaldehyde for 15 min and stained with 1% crystal violet for 30 min before counting the plaques. MTT assay Vero cells were seeded at a density of 5×103 cells/well in 96-well plate and cultured 12 h. After C646 treatment, 5 µl of MTT (5 µg/ml) were added to each well, and the plate wasincubated for 4 h at 37℃. Then 100 µl of solubilization buffer (50%DNF and 30%SDS in distilled water) were added to each well, and the plate was incubated for 4 h at 37℃. After the incubation, the absorbance was measured at 570 nm in a microplate reader. Statistical analysis For all the experimental studies, the assays were repeated at least three times. At least two biological replicates were performed for deep sequencing experiments For all other experiments, at least three biological replicates were studied. Data were shown as average values ± SD and p value. Student’s t-test was used for comparison between two groups. One-way ANOVA coupled with Tukey’s post hoc test was used for comparisons over two groups. For the meta-analysis, the statistical analysis approach was described in the corresponding sections. Data access The original files of next generation sequencing are uploaded to GEO database with the following Acc. No. GSE124803. Acknowledgments This work was supported by grants from Ministry of Science and Technology of China (2016YFA0502100), National Natural Science Foundation of China to L.L. (31670874) and M.W. (31771503 and 81972647), Science and Technology Department of Hubei Province of China (CXZD2017000188).We thank Dr. Hong-Bing Shu of Wuhan University for reagents. References Bate-Eya, L.T., Gierman, H.J., Ebus, M.E., Koster, J., Caron, H.N., Versteeg, R., Dolman, M.E.M., Molenaar, J.J., 2017. Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity. Eur 15
J Cancer 75, 63-72. Bhaumik, S.R., Smith, E., Shilatifard, A., 2007. Covalent modifications of histones during development and disease pathogenesis. Nat Struct Mol Biol 14, 1008-1016. Bowers, E.M., Yan, G., Mukherjee, C., Orry, A., Wang, L., Holbert, M.A., Crump, N.T., Hazzalin, C.A., Liszczak, G., Yuan, H., Larocca, C., Saldanha, S.A., Abagyan, R., Sun, Y., Meyers, D.J., Marmorstein, R., Mahadevan, L.C., Alani, R.M., Cole, P.A., 2010. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol 17, 471-482. Brookes, E., Shi, Y., 2014. Diverse epigenetic mechanisms of human disease. Annu Rev Genet 48, 237-268. Cliffe, A.R., Garber, D.A., Knipe, D.M., 2009. Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters. J Virol 83, 8182-8190. Conn, K.L., Schang, L.M., 2013. Chromatin dynamics during lytic infection with herpes simplex virus 1. Viruses 5, 1758-1786. Harkness, J.M., Kader, M., DeLuca, N.A., 2014. Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells. J Virol 88, 6847-6861. Henikoff, S., Shilatifard, A., 2011. Histone modification: cause or cog? Trends Genet 27, 389-396. Hill, J.M., Quenelle, D.C., Cardin, R.D., Vogel, J.L., Clement, C., Bravo, F.J., Foster, T.P., Bosch-Marce, M., Raja, P., Lee, J.S., Bernstein, D.I., Krause, P.R., Knipe, D.M., Kristie, T.M., 2014. Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes. Science translational medicine 6, 265ra169. Hilton, I.B., Simon, J.M., Lieb, J.D., Davis, I.J., Damania, B., Dittmer, D.P., 2013. The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus. J Virol 87, 11831-11842. Huang da, W., Sherman, B.T., Lempicki, R.A., 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57. James, S.H., Kimberlin, D.W., 2015. Neonatal Herpes Simplex Virus Infection. Infectious disease clinics of North America 29, 391-400. Kent, J.R., Zeng, P.Y., Atanasiu, D., Gardner, J., Fraser, N.W., Berger, S.L., 2004. During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J Virol 78, 10178-10186. Kristie, T.M., 2015. Dynamic modulation of HSV chromatin drives initiation of infection and provides targets for epigenetic therapies. Virology 479-480, 555-561. Lacasse, J.J., Schang, L.M., 2012. Herpes simplex virus 1 DNA is in unstable nucleosomes throughout the lytic infection cycle, and the instability of the nucleosomes is independent of DNA replication. J Virol 86, 11287-11300. Langmead, B., Salzberg, S.L., 2012. Fast gapped-read alignment with Bowtie 2. Nature methods 9, 357-359. Lee, J.S., Raja, P., Knipe, D.M., 2016. Herpesviral ICP0 Protein Promotes Two Waves of Heterochromatin Removal on an Early Viral Promoter during Lytic Infection. mBio 7, 16
e02007-02015. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., Genome Project Data Processing, S., 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079. Li, Q.L., Lei, P.J., Zhao, Q.Y., Li, L., Wei, G., Wu, M., 2017. Epigenomic analysis in a cell-based model reveals the roles of H3K9me3 in breast cancer transformation. Epigenomics 9, 1077-1092. Li, Q.L., Wang, D.Y., Ju, L.G., Yao, J., Gao, C., Lei, P.J., Li, L.Y., Zhao, X.L., Wu, M., 2019. The hyper-activation of transcriptional enhancers in breast cancer. Clinical epigenetics 11, 48. Liang, Y., Vogel, J.L., Narayanan, A., Peng, H., Kristie, T.M., 2009. Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat Med 15, 1312-1317. Medina-Rivera, A., Santiago-Algarra, D., Puthier, D., Spicuglia, S., 2018. Widespread Enhancer Activity from Core Promoters. Trends Biochem Sci 43, 452-468. Oh, J., Sanders, I.F., Chen, E.Z., Li, H., Tobias, J.W., Isett, R.B., Penubarthi, S., Sun, H., Baldwin, D.A., Fraser, N.W., 2015. Genome wide nucleosome mapping for HSV-1 shows nucleosomes are deposited at preferred positions during lytic infection. PLoS One 10, e0117471. Peters, A.H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schofer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., Opravil, S., Doyle, M., Sibilia, M., Jenuwein, T., 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107, 323-337. Quinlan, A.R., Hall, I.M., 2010. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842. Rickels, R., Shilatifard, A., 2018. Enhancer Logic and Mechanics in Development and Disease. Trends Cell Biol 28, 608-630. Shah, G.A., O'Shea, C.C., 2015. Viral and Cellular Genomes Activate Distinct DNA Damage Responses. Cell 162, 987-1002. Sun, R., Tan, X., Wang, X., Wang, X., Yang, L., Robertson, E.S., Lan, K., 2017. Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues. PLoS Pathog 13, e1006167. Thellman, N.M., Triezenberg, S.J., 2017. Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency. Pathogens 6. Toth, Z., Brulois, K., Jung, J.U., 2013. The chromatin landscape of Kaposi's sarcoma-associated herpesvirus. Viruses 5, 1346-1373. Toth, Z., Maglinte, D.T., Lee, S.H., Lee, H.R., Wong, L.Y., Brulois, K.F., Lee, S., Buckley, J.D., Laird, P.W., Marquez, V.E., Jung, J.U., 2010. Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog 6, e1001013. Whitley, R.J., Roizman, B., 2001. Herpes simplex virus infections. Lancet 357, 1513-1518. Zhu, K., Lei, P.J., Ju, L.G., Wang, X., Huang, K., Yang, B., Shao, C., Zhu, Y., Wei, G., Fu, X.D., Li, L., Wu, M., 2017. SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing. Nucleic Acids Res 45, 92-105. 17
18
Figure legends Fig. 1 Enrichment of histone modifications on HSV-1 genomes in THP-1 cells. (A-D) THP-1 cells were infected with HSV-1 and 1 h later, cells were harvested and ChIP assay was performed. The histone modifications on viral gB gene, H3K9me3 (A), H3K27me3 (B), H3K27ac (C) and H3K4me3 (D), were measured with quantitative PCR. The host gene GAPDH was a negative control for H3K9me3 and H3K27me3, and a positive control for H3K27ac and H3K4me3. The host gene MYT1 was a positive control for H3K9me3 and H3K27me3. The host centromere region in chromosome 7 was a negative control for H3K27ac and H3K4me3. (E-H) THP-1 cells were infected with HSV-1 and harvested at the indicated time points. H3K9me3 (E), H3K27me3 (F), H3K27ac (G) and H3K4me3 (H) on gB were measured with ChIP assay. * means p value < 0.05; ** means p value < 0.01; NS, non-significant. Fig. 2 The dynamic gene expression of HSV-1 in THP-1 cells. (A) The reads count of RNA-Seq data on HSV-1 genome at each time point. (B) HSV-1 Copy number at each time point, represented by the ratio of the nucleotide base number of input sequences mapped to HSV-1 genome divided by the size of HSV-1 genome. The nucleotide base number was normalized to the mapping number of host genome. (C) The relative reads count of H3K27ac, H3K27me3, H3K4me3, H3K9me3 and Input samples on HSV-1 genomes at different time points, which were normalized to the host cell genome and the corresponding value at 1 h, which represents the average value in each cell. (D) Distribution of RNA-seq reads across the HSV-1 genome at each time point. The locations of reads for each time point were shown relative to a map of the mRNA for each HSV-1 gene. The average mRNA level of single virus was shown after normalization to the number of host mapped reads and relative copy number. The structure and coding genes of HSV-1 reference genome are shown at the bottom of the figure. Fig. 3 The dynamic epigenomic landscapes of histone modifications of HSV-1. (A - D) H3K9me3 (A), H3K27me3 (B), H3K4me3 (C) and H3K27ac (D) on HSV-1 genome at different time points. The y axis represents the enrichment of modifications on HSV-1 genome, which was shown by the reads number normalized by the host mapped reads and virus copy number at the corresponding time points.
19
Fig. 4 The dynamics of H3K27ac, H3K27me3, H3K4me3 and H3K9me3 during the infection process. (A & B) The average level of gene expression (A) and histone modifications (B) of each HSV-1 virus. The y-axis represents the normalized mapped read number of RNA or histone modifications normalized by the number of host genome and relative viral genome in the input sample at each time point, which represents the average value of each virus. (C) The Spearman’s correlation of histone modifications on human genome (hg19). The colors represent the rate of correlation. (D) The Spearman’s correlation of histone modifications on HSV-1 genome. Fig. 5 The association of histone modifications and viral gene expression. (A) The gene expression level of all HSV-1 genes at 1 h, 2 h, 4 h, 8 h and 24 h after infection. The RNA level of each gene was calculated by adding up all reads on the gene body and normalized with the corresponding host mapped reads and the relative copy number. The change of gene expression at different time points was shown with Z score. (B) Heat maps to show the enrichment of H3K27ac on all HSV-1 genes. The values of the indicated histone modifications were calculated by adding up all reads on the gene body, and normalized with the corresponding mapped reads to host genome and the relative virus copy number. The change of histone modification in each row was shown with Z score. (C) Scatterplots showing relationships between mRNA and H3K27ac on all HSV-1 genes. Pearson correlations and p values are indicated. Linear models are shown as black line. (D-F) Heat maps to show the enrichment of H3K27me3 (D) and H3K9me3 (E) and H3K4me3 (F) on all HSV-1 genes. Data were analyzed as that in (B). Fig.6 The anti-viral functions of epigenetic inhibitor C646. (A) The normalized gene expression level of HSV-1 in THP-1 treated with C646, DMSO and EPZ6438. The Y axis represents the number of all the mapped HSV-1 reads, normalized by the mapped total RNA reads to host genomes and divided by the length of the viral genome. (B & C) Distribution of RNA-seq reads across the HSV-1 genome treated with C646 (B) or EPZ6438 (C). The scales of the graphs were normalized to the number of total mapped reads. (D) The differential expressed genes after C646 treatment. Up-regulated genes were labeled in red and down-regulated genes in green. (E & F)The gene ontology and pathway analysis of the up-regulated genes (E) and down-regulated genes (F). 20
Highlights 1. Histone modifications on viral genome is tightly controlled and change rapidly. 2. H3K27ac gradually increases along with virus life cycle. 3. H3K27me3 and H3K9me3 are enriched at the early stage and decreases during infection. 4. A chemical inhibitor of H3K27ac greatly repressed HSV-1 replication.